You Position: Home > Paper
Recent advances in anti-scarring agents for glaucoma filtration surgery
( views:289, downloads:60 )
- Author:
- No author available
- Journal Title:
- INTERNATIONAL EYE SCIENCE
- Issue:
- 8
- DOI:
- 10.3969/j.issn.1672-5123.2012.08.24
- Key Word:
- 抗瘢痕药物;青光眼;滤过手术
Abstract： 青光眼是临床常见致盲眼病,目前以手术治疗为主,但术后复发率较高,主要原因是术区成纤维细胞增生,致瘢痕形成阻塞滤过道.为提高手术成功率,一些抗瘢痕形成的药物被越来越多的应用于青光眼滤过手术的实验与临床研究中,但这些药物也有一定的并发症及毒副作用.随着医疗技术的进步,人们正在寻找更为安全有效的给药方式和新的抑制瘢痕形成的药物.
- [1]吴萍,何晓晓,王柯敏,等.基于壳聚糖载体的蛋白质药物纳米颗粒制备研究[J].2007,(9).
- [2]张欣,梁春玲,徐彦,等.非穿透性小梁手术中应用丝裂霉素C32例[J].2005,(1).
- [3]白先枝,周雄武,赵长松.非穿透小梁手术联合丝裂霉素C治疗原发性开角型青光眼17例[J].2004,(1).
- [4]廖海兰,梁轩伟,魏建初.抗TGF-β2抗体对青光眼滤过泡瘢痕成纤维细胞周期的影响[J].2008,(3).
- [5]杨力,郭树忠.成纤维细胞与创伤修复的生物学过程[J].2002,(4).
- [6]寿成珉,黄晓丹,张惠成.青光眼滤过性手术抗瘢痕形成药物的进展[J].2002,(2).
- [7]王琳,惠延年,韩泉洪,等.晶状体超声乳化、折叠人工晶状体植入和小梁切除联合手术治疗闭角型青光眼[J].2004,(1).
- [8]李俊英.青光眼滤过术中联合应用环孢霉素A临床观察[J].2002,(6).
- [9]戴丽华,李维宁,乔智.全反式维甲酸对体外培养的人Tenon囊成纤维细胞增殖及凋亡的影响[J].2007,(4).
- [10]张彦,王万辉.维生素E族在青光眼滤过性手术后抗瘢痕作用的初步研究[J].2007,(3).
- [11]宋健,朱樑,张兴荣,等.几丁糖对成纤维细胞增殖及Ⅲ型前胶原信使核糖核酸表达的影响[J].2001,(1).
- [12]李丹,刘兵,林军军,等.丝裂霉素C辅助兔青光眼滤过手术的电镜观察[J].2003,(4).
- [13]申颖,艾育德.GM6001在兔眼滤过性手术中抗瘢痕作用的实验研究[J].2008,(9).
- [14]张月玲,冯丽,张海江,等.医用几丁糖在青光眼滤过术后抗瘢痕的研究[J].2005,(1).
- [15]谢琳,贺翔鸽.TGF-β抑制剂（Decorin）抗滤过泡瘢痕形成及毒副作用的实验研究[J].2001,(9).
- [16]张志峰,孙厚壮,刘爱英.透明质酸钠在青光眼小梁切除术中的临床应用探讨[J].2009,(16).
- [17]张立贵.透明质酸钠在治疗青光眼中的应用[J].2002,(2).
- [18]Mead A,Daniels JT,Cordeiro MF,etc.Modulation of wound healing after glaucoma surgery.[J].2001,12(2).
- [19]Ferreira AM,Bergdall VK,Wilgus TA,etc.Regulation of scar formation by vascular endothelial growth factor.[J].2008,88(6).
- [20]Lee DA,Higginbotham EJ.Glaucoma and its treatment: a review.[J].2005,62(7).
- [21]Wettschureck N,Offermanns S.Rho/Rho-kinase mediated signaling in physiology and pathophysiology.[J].2002,80(10).
- [22]Hamard P,Lachkar Y.Nonpenetrating filtering surgery.[J].2002,13(2).
- [23]Chang L,Wilkins MR,Crowston JG,etc.In vivo production of interferon beta by human Tenon's fibroblasts; a possible mediator for the development of chronic conjunctival inflammation.[J].2002,86(6).
- [24]Goldblum D,Meyenberg A,Mojon D.Dietary tocopherol supplementation after trabeculectomy and phacotrabeculectomy: double-blind randomized placebo-controlled trial.[J].2009,223(4).
- [25]Dornish M,Wood EJ,Dettmar PW,etc.The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro.[J].2001,22(22).
- [26]Gregory L. Skuta,Adam C. Reynolds,Sean-Paul A. Atreides.Wound Healing Modulation in Glaucoma Filtering Surgery[J].2004,44(2).
- [27]Khaw PT,Cordeiro MF,Crowston JG,etc.The role of the immune system in conjunctival wound healing after glaucoma surgery.[J].2000,45(1).
- [28]Ron, Ofri.Intraocular pressure and glaucoma.[J].2002,5.
- [29]Mead AL,Khaw PT,Wong TT.Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery.[J].2003,44(3).
- [30]Georgiadis N,Halvatzis N,Moschou V,etc.Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation.[J].2003,29(4).
- [31]Petermeier K,Henke-Fahle S,Grisanti S,etc.The Rho-kinase inhibitor H-1152P suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro.[J].2007,48(5).
- [32]R CTripathi,B JTripathi.Tissue plasminogen activator therapy for the eye[J].2005,89(11).